By Adam L. Cataldo Humanigen shares dropped after a proposed business combination fell through and the company said it may be forced to cease operations and.
Humanigen, Inc. (NASDAQ:HGEN – Get Free Report) shares traded up 5.6% during trading on Tuesday . The stock traded as high as $0.18 and last traded at $0.18. 1,842,578 shares changed hands during mid-day trading, a decline of 24% from the average session volume of 2,412,193 shares. The stock had previously closed at $0.17. Analyst […]
Credit Suisse Group restated their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a report issued on Monday morning, Benzinga reports. The firm currently has a $0.50 price objective on the stock. Separately, Cantor Fitzgerald initiated coverage on Humanigen in a research report on Wednesday, January 11th. They set a neutral rating […]
Credit Suisse Group reissued their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a research note released on Monday, Benzinga reports. They currently have a $0.50 target price on the stock. Separately, Cantor Fitzgerald initiated coverage on shares of Humanigen in a research note on Wednesday, January 11th. They set a neutral […]
Humanigen, Inc. (NASDAQ:HGEN – Get Rating) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 6,540,000 shares, a decline of 9.7% from the February 28th total of 7,240,000 shares. Based on an average trading volume of 3,470,000 shares, the short-interest ratio is presently […]